News

FDA commissioner stirs debate over hormone therapy for menopause
A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
BizPac Review1h
‘All of us are begging’: New push for FDA to remove ‘black box’ warnings from menopause products
The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...
How one controversial study shaped 20 years of menopause care
Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...
A new stem cell treatment could relieve type 1 diabetes symptoms, according to Penn doctors
Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading ...
7/22 -- CTM DONE- Transgender Americans Braced For Loss Of Gender-Affirming Care
By Dennis Thompson HealthDay ReporterTUESDAY, July 22, 2025 (HealthDay News) — Just about all transgender Americans believe they’ll lose their access to gender-affirming health care during President ...
The new stage four cancer treatments and what they mean for patients
A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...
Targeted Oncology21h
Understanding ARPIs to Make Therapy Selection in Prostate Cancer
Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.
Scientific American10h
First Hormone-Free Male Birth Control Pill Shown Safe in Early Human Trial
A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing ...